Equinor Sees COVID Accelerating Peak Oil Demand To 2027-2028
Slower demand growth due to the pandemic and a drop in global oil supply due to low investments could result in peak oil demand 2-3 years sooner than an earlier Continue Reading
Slower demand growth due to the pandemic and a drop in global oil supply due to low investments could result in peak oil demand 2-3 years sooner than an earlier Continue Reading
France‘s second lockdown will push the economy back into a slump and slow the recovery in 2021, even though restrictions to contain the coronavirus aren’t as severe as earlier in Continue Reading
U.K. Prime Minister Boris Johnson announced a 12 billion-pound ($15.9 billion) plan to boost green industries and tackle climate change, in a blueprint he says will create or support as many Continue Reading
After a one-month reprieve, passenger car sales in Europe slumped again in October amid new restrictions in many countries aimed at containing a resurgence of the coronavirus, the European carmakers’ Continue Reading
Norway’s Equinor will raise crude production from its flagship Johan Sverdrup field to 500,000 b/d by year-end from 470,000 b/d, with the second phase of the project eventually taking production Continue Reading
UK Prime Minister Boris Johnson announced a 10-point climate change plan late Nov. 17, promising GBP12 billion ($15.93 billion) of investment in a range of decarbonization initiatives while bringing forward Continue Reading
Crude oil futures ticked higher during mid-morning Asian trade Nov. 17 as reports of a highly effective Moderna vaccine carried the markets despite rising concerns over the number of COVID-19 Continue Reading
Oil fluctuated near $41 a barrel as the dollar fell and traders weighed the potential for OPEC+ to delay a planned easing of output cuts. While headline prices have gained on Continue Reading
This year has been a true rollercoaster ride for the U.S. stock market, but it is increasingly looking to end on a high note. The S&P 500 has climbed nearly Continue Reading
Moderna Inc’s experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report Continue Reading